1. Home
  2. FTHM vs CELU Comparison

FTHM vs CELU Comparison

Compare FTHM & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fathom Holdings Inc.

FTHM

Fathom Holdings Inc.

BUY

Current Price

$1.07

Market Cap

31.5M

Sector

Finance

ML Signal

BUY

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.76

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTHM
CELU
Founded
2010
2016
Country
United States
United States
Employees
N/A
123
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.5M
35.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
FTHM
CELU
Price
$1.07
$0.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$2.50
$6.00
AVG Volume (30 Days)
3.8M
136.3K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
32.71
N/A
EPS
N/A
N/A
Revenue
$420,477,000.00
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
25.45
N/A
52 Week Low
$0.40
$0.67
52 Week High
$3.37
$4.35

Technical Indicators

Market Signals
Indicator
FTHM
CELU
Relative Strength Index (RSI) 74.49 41.00
Support Level $0.85 $0.69
Resistance Level $1.18 $1.43
Average True Range (ATR) 0.11 0.12
MACD 0.07 -0.01
Stochastic Oscillator 65.05 20.91

Price Performance

Historical Comparison
FTHM
CELU

About FTHM Fathom Holdings Inc.

Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: